| PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology | 09/13 08:30 | globenewswire.com |
| Aclarion Provides Corporate Update on Nociscan AI Technology Milestones | 09/12 06:57 | globenewswire.com |
| Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial | 09/10 06:57 | globenewswire.com |
| Aclarion Added to PRISM Emerging Medical Devices Index | 09/06 11:29 | prismmediawire.com |
| Aclarion Launches Surgeon Partnership to Apply Nociscan's AI Technology to Personal Injury and Workers Compensation Market | 09/05 06:57 | globenewswire.com |
| Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey | 08/29 06:57 | globenewswire.com |
| Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan's AI Generated Biomarker Data Changes Surgical Treatment Plans | 08/21 07:57 | globenewswire.com |
| Aclarion to Present at August 20th Virtual Investor Summit Microcap Event | 08/15 09:48 | globenewswire.com |
| Aclarion Announces First Commercial Agreement in Michigan | 08/14 08:08 | globenewswire.com |